4.8 Article

Poly(D,L-lactide-ran-ε-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-ε-caprolactone) as parenteral drug-delivery systems

期刊

BIOMATERIALS
卷 25, 期 17, 页码 3733-3742

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2003.09.106

关键词

poly(D,L-lactide-ran-epsilon-caprolactone); poly(ethylene glycol); drug release behavior; parenteral drug-delivery system; tri-block copolymer

向作者/读者索取更多资源

P(DLA(chi)-ran-CLY)(n)-b-PEG-b-P(DLA(chi)-ran-CLY)(n)s (P(DLA(chi)-ran-CLY)(m): Poly(D,L-lactide-ran-epsilon-caprolactone), PEG: Poly(ethylene glycol), X: D,L-lactyl unit ratio, Y: epsilon-caproyl unit ratio, m: molecular weight of P(DLA(chi)-ran-CLY)), were investigated as the novel parenteral drug-delivery system. The thermal behavior in the DSC characterization and variable viscosity with temperature suggest their potential usuage as a injectable drug-delivery system. The variation of tri-block structure affects the drug release behavior by changing the morphology and also by changing the interaction between the polymer matrix and the hydrophilic drug. (C) 2003 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据